BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 2110576)

  • 1. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
    McLachlan RI; Finkel DM; Bremner WJ; Snyder PJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1414-9. PubMed ID: 2110576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
    Finkel DM; Phillips JL; Snyder PJ
    N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicle-stimulating hormone is required for quantitatively normal inhibin secretion in men.
    McLachlan RI; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1305-8. PubMed ID: 3142919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement--a clinical research center study.
    Seminara SB; Boepple PA; Nachtigall LB; Pralong FP; Khoury RH; Sluss PM; Lecain AE; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3692-6. PubMed ID: 8855824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibin B, FSH, LH and testosterone levels before and after human chorionic gonadotropin stimulation in prepubertal boys with cryptorchidism.
    Christiansen P; Andersson AM; Skakkebaek NE; Juul A
    Eur J Endocrinol; 2002 Jul; 147(1):95-101. PubMed ID: 12088925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man.
    Scott RS; Burger HG
    J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism.
    Saal W; Happ J; Cordes U; Baum RP; Schmidt M
    Fertil Steril; 1991 Aug; 56(2):319-24. PubMed ID: 1906410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.
    McLachlan RI; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Invest; 1988 Sep; 82(3):880-4. PubMed ID: 3138288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibin, steroid hormone, and gonadotropin concentration in blood from fertile and infertile males and its relationship with testicular function].
    Chavarría ME; Díaz-Sánchez V; McLachlan RI; Domville E; Tapia R
    Ginecol Obstet Mex; 1991 Mar; 59():85-92. PubMed ID: 1860676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
    Matsumoto AM; Karpas AE; Bremner WJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypogonadotropic eunuchoidism. II. Gonadal responsiveness to exogenous gonadotropins.
    Santen RJ; Paulsen CA
    J Clin Endocrinol Metab; 1973 Jan; 36(1):55-63. PubMed ID: 4404633
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction.
    Anawalt BD; Bebb RA; Matsumoto AM; Groome NP; Illingworth PJ; McNeilly AS; Bremner WJ
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3341-5. PubMed ID: 8784094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.